Dr. Reddy’s said today that it has sold its API manufacturing plant in Hyderabad to Therapiva, a joint venture of Abu Dhabi-based Neopharma and India’s Laxai Life Sciences, an emerging ...

Dr. Reddy’s has spent nearly five years trying to get out from under a warning letter for an important API plant in India but has yet to shake off all of the FDA’s concerns.

Dr Reddy’s: API unit sale should lower costs, may not be a windfall Although Dr Reddy's has not disclosed details such as consideration or revenues of the units sold in both transactions ...